Cannabinoid 101: CBV

One hundred and thirteen.

That’s how many known cannabinoids have been discovered within the cannabis plant. There are a couple that are known well among the public. Delta 9 THC is the main psychoactive cannabinoid in marijuana that creates the euphoric high that consumers want. There’s also CBD, which is a non-psychoactive cannabinoid that has been shown in research and reported by consumers that has many beneficial effects. But what about the other cannabinoids? What are they and what do they do? Scientists are actually still figuring that out. But there is some information about some of them. Let’s take a look at CBV.

Cannabivarin

CBV, known as cannabivarin as well as cannabivarol, is a non-psychoactive cannabinoid similar to CBN. It’s the second most abundant cannabinoid within the plant itself. But if you pick a fresh plant and break it down into its different cannabinoides, you would hardly find any of it. That’s because CBV is an oxidative form of another cannabinoid, THCV. This makes CBV interesting, because if you consume CBV and take a drug test, you will test positive for THC even if CBV is more abundant in your system. 

Research

Like many other cannabinoids, there has been little research conducted on CBV. There is the potential for the cannabinoid to affect the endocannabinoid system within the human body, but nothing has been conclusively stated. 

Because of CBV’s similarity to CBN, scientists have speculated what CBV could do. These speculations include helping with mood disorders, pain, appetite control, sleep-work cycle, and tumor reduction. Nothing can be stated as of yet but since the reclassification of hemp thanks to the Farm Bill in 2018, the avenue for hemp research, which would include CBV, would be open for further studies. When more information is discovered about this cannabinoid, we will be sure to update you.

Have you tried any cannabinoid products? What did you think of them? Let us know in the comments below. And, as always, check back for more cannabinoid news and reviews

Leave a Reply

Your email address will not be published. Required fields are marked *